Woodline Partners’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.3M | Hold |
349,664
| – | – | 0.15% | 201 |
|
|
2025
Q1 | $25M | Buy |
349,664
+48,102
| +16% | +$3.44M | 0.16% | 185 |
|
|
2024
Q4 | $13.6M | Sell |
301,562
-100,521
| -25% | -$4.52M | 0.09% | 285 |
|
|
2024
Q3 | $20.3M | Buy |
402,083
+82,878
| +26% | +$4.18M | 0.17% | 190 |
|
|
2024
Q2 | $13M | Buy |
319,205
+212,745
| +200% | +$8.68M | 0.12% | 218 |
|
|
2024
Q1 | $4.56M | Sell |
106,460
-93,540
| -47% | -$4M | 0.04% | 367 |
|
|
2023
Q4 | $8.05M | Sell |
200,000
-63,860
| -24% | -$2.57M | 0.09% | 252 |
|
|
2023
Q3 | $7.79M | Buy |
+263,860
| New | +$7.79M | 0.09% | 249 |
|